- Nachrichtendetail
-
12.07.2024 14:33:04 - dpa-AFX: *ABBVIE SEEKS FDA AND EMA APPROVAL FOR UPADACITINIB IN GIANT CELL ARTERITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE INC. DL-,01 | A1J84E | Xetra | 176,600 | 21.08.24 09:06:35 | +0,860 | +0,49% | 176,340 | 177,640 | 176,620 | 175,740 |
